|
A Specialized Diagnostics leader, Werfen delivers Hemostasis, Acute Care, Autoimmunity, and OEM solutions to Power Patient Care. In 2023, we acquired Immucor, adding Transfusion and Transplant to our portfolio. Key products: ACL TOP® Family 50 Series, HemosIL® assays, HemoHub®; GEM® Premier™ 5000, GEM Premier ChemSTAT®, GEM Hemochron™ 100, ROTEM® sigma, VerifyNow™, GEMweb® Plus 500; Aptiva®, BIO-FLASH®, QUANTA-Lyser®, QUANTA-Link®; Echo Lumena®, NEO Iris®; assays/biomat for IVD industry. For more information visit our website: https://www.werfen.com/na/en
Debbie Britch, BSN, RN, MSL-BC
|
